Post by
jh1970 on May 30, 2024 2:08pm
Who is a Christophe Degois ?
He got 200K option grant today as per sedi.
Comment by
Noteable on May 30, 2024 2:15pm
Filed 2024-05-30 08:36 Tx date 2024-05-28 $ONC Oncolytics Biotech Inc. Degois, Christophe 5 - Senior Officer of Issuer Direct Ownership Options 50 - Grant of options $306,000 +200,000 vol $1.53 each 200,000
Comment by
Noteable on May 30, 2024 2:34pm
Andrew-de-Guttadauro knows him ... which is a black smudge right from the start.
Comment by
Noteable on May 30, 2024 3:15pm
de-Guttadauro's endorsement is not inspiring.
Comment by
Azzak34 on May 30, 2024 3:48pm
Andrew may well have been useless but the fact he knows who this guy is has no bearing on what Degois does for a living. This fella gets deals done.
Comment by
Noteable on May 30, 2024 4:06pm
" ... The proof will be in the pudding ..."
Comment by
Noteable on May 30, 2024 4:20pm
" ... not an entirely illuminating history of performance ...."
Comment by
CMHarring218431 on May 30, 2024 4:41pm
I thought his linkedin profile etc was actually fairly impressive. Works for a company which to me, aside from the technical and targeted approach they are focusing on......sounds like ONC. Would ONC award the options if an alliance, partnership or some agreement has not been consummated? There has to be something there
Comment by
Noteable on May 30, 2024 4:57pm
" Would ONC award the options if an alliance, partnership or some agreement has not been consummated? " .. Yes. Just look at the appointments of the last 3 directors. They haven't brought anything.
Comment by
CMHarring218431 on May 30, 2024 5:13pm
Yeah, I get that part. But, those were incentive bonuses, so to speak. A monetary gift of sorts without guys check out of the Treasury. This guy is an outsider who must have granted the options as a form of thanks and reward.
Comment by
Noteable on May 30, 2024 5:20pm
There aren't any "thanks" -- and here are your options as quid pro quo.The directors were also "outsiders" who received options and brought nothing other than empty promises.
Comment by
Azzak34 on May 30, 2024 5:20pm
I'm always ok with having more people who have demonstrable experience in getting drugs approved and deals signed. Particularly if they're only being paid in future considerations. I take Notes point about how stacked does the board have to be to get this done. 1 more can't hurt. Questions could be asked about what Parsons and Rigby have been up to!!
Comment by
Noteable on May 30, 2024 5:33pm
Once again ... " ... The proof will be in the pudding ..."
Comment by
spesestsemper on May 30, 2024 6:45pm
Am i missing something here . It says he is a senior officer , not a director . So is he the new CEO, president , vp , cfo . Usually there is a news release stating what his title is . Hopefully if he is a new ceo , he will take care of details like this . They wonder why its hard to drum up interest . things like this matter for a public company .